[1]
|
Uchida, K. (2022) Waste Clearance in the Brain and Neuroinflammation: A Novel Perspective on Biomarker and Drug Target Discovery in Alzheimer’s Disease. Cells, 11, Article No. 919. https://doi.org/10.3390/cells11050919
|
[2]
|
Soria Lopez, J.A., González, H.M. and Léger, G.C. (2019) Alzheimer’s Disease. In: Handbook of Clinical Neurology, Vol. 167, Elsevier, Amsterdam, 231-255. https://doi.org/10.1016/B978-0-12-804766-8.00013-3
|
[3]
|
Jia, L., Du, Y., Chu, L., et al. (2020) Prevalence, Risk Factors, and Management of Dementia and Mild Cognitive Impairment in Adults Aged 60 Years or Older in China: A Cross-Sectional Study. The Lancet Public Health, 5, e661-e671.
https://doi.org/10.1016/S2468-2667(20)30185-7
|
[4]
|
Jia, J., Wei, C., Chen, S., et al. (2018) The Cost of Alz-heimer’s Disease in China and Re-Estimation of Costs Worldwide. Alzheimer’s & Dementia, 14, 483-491. https://doi.org/10.1016/j.jalz.2017.12.006
|
[5]
|
Tiwari, S., Atluri, V., Kaushik, A., et al. (2019) Alzheimer’s Dis-ease: Pathogenesis, Diagnostics, and Therapeutics. International Journal of Nanomedicine, 14, 5541-5554. https://doi.org/10.2147/IJN.S200490
|
[6]
|
Olsson, B., Lautner, R., Andreasson, U., et al. (2016) CSF and Blood Biomarkers for the Diagnosis of Alzheimer’s Disease: A Systematic Review and Meta-Analysis. The Lancet Neurology, 15, 673-684.
https://doi.org/10.1016/S1474-4422(16)00070-3
|
[7]
|
Suárez-Calvet, M., Karikari, T.K., Ashton, N.J., et al. (2020) Novel Tau Biomarkers Phosphorylated at T181, T217 or T231 Rise in the Initial Stages of the Preclinical Alzheimer’s Continuum When Only Subtle Changes in Aβ Pathology Are Detected. EMBO Molecular Medicine, 12, e12921.
|
[8]
|
Blennow, K., Hampel, H., Weiner, M., et al. (2010) Cerebrospinal Fluid and Plasma Biomarkers in Alz-heimer Disease. Nature Reviews Neurology, 6, 131-144. https://doi.org/10.1038/nrneurol.2010.4
|
[9]
|
Wang, J., Qiao, F., Shang, S., et al. (2018) Elevation of Plasma Amyloid-β Level Is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study. Journal of Alzheimer’s Disease, 64, 61-69.
https://doi.org/10.3233/JAD-180140
|
[10]
|
Nakamura, A., Kaneko, N., Villemagne, V.L., et al. (2018) High Per-formance Plasma Amyloid-β Biomarkers for Alzheimer’s Disease. Nature, 554, 249-254. https://doi.org/10.1038/nature25456
|
[11]
|
Verberk, I.M.W., Slot, R.E., Verfaillie, S.C.J., et al. (2018) Plasma Am-yloid as Prescreener for the Earliest Alzheimer Pathological Changes. Annals of Neurology, 84, 648-658. https://doi.org/10.1002/ana.25334
|
[12]
|
Mielke, M.M., Hagen, C.E., Wennberg, A.M.V., et al. (2017) Association of Plasma Total Tau Level with Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging. JAMA Neurology, 74, 1073-1080. https://doi.org/10.1001/jamaneurol.2017.1359
|
[13]
|
Yang, C.C., Chiu, M.J., Chen, T.F., et al. (2018) Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease. Journal of Alzheimer’s Disease, 61, 1323-1332.
https://doi.org/10.3233/JAD-170810
|
[14]
|
Calsolaro, V. and Edison, P. (2016) Neuroinflammation in Alzheimer’s Disease: Current Evidence and Future Directions. Alzheimer’s & Dementia, 12, 719-732. https://doi.org/10.1016/j.jalz.2016.02.010
|
[15]
|
Italiani, P., Puxeddu, I., Napoletano, S., et al. (2018) Circulating Levels of IL-1 Family Cytokines and Receptors in Alzheimer’s Disease: New Markers of Disease Progression? Journal of Neuroinflammation, 15, 342.
https://doi.org/10.1186/s12974-018-1376-1
|
[16]
|
Wang, L., Gao, T., Cai, T., et al. (2020) Cerebrospinal Fluid Lev-els of YKL-40 in Prodromal Alzheimer’s Disease. Neuroscience Letters, 715, Article ID: 134658. https://doi.org/10.1016/j.neulet.2019.134658
|
[17]
|
Villar-Piqué, A., Schmitz, M., Hermann, P., et al. (2019) Plasma YKL-40 in the Spectrum of Neurodegenerative Dementia. Journal of Neuroinflammation, 16, Article No. 145. https://doi.org/10.1186/s12974-019-1531-3
|
[18]
|
Heslegrave, A., Heywood, W., Paterson, R., et al. (2016) In-creased Cerebrospinal Fluid Soluble TREM2 Concentration in Alzheimer’s Disease. Molecular Neurodegeneration, 11, Article No. 3. https://doi.org/10.1186/s13024-016-0071-x
|
[19]
|
Lee, W.J., Liao, Y.C., Wang, Y.F., et al. (2018) Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-Year Follow-Up Study. Scientific Reports, 8, Article No. 1280.
https://doi.org/10.1038/s41598-018-19807-y
|
[20]
|
Shen, X.N., Niu, L.D., Wang, Y.J., et al. (2019) Inflammatory Markers in Alzheimer’s Disease and Mild Cognitive Impairment: A Meta-Analysis and Systematic Review of 170 Stud-ies. Journal of Neurology, Neurosurgery and Psychiatry, 90, 590-598. https://doi.org/10.1136/jnnp-2018-319148
|
[21]
|
Montagne, A., Nation, D.A., Sagare, A.P., et al. (2020) APOE4 Leads to Blood-Brain Barrier Dysfunction Predicting Cognitive Decline. Nature, 581, 71-76. https://doi.org/10.1038/s41586-020-2247-3
|
[22]
|
Skillbäck, T., Delsing, L., Synnergren, J., et al. (2017) CSF/Serum Albumin Ratio in Dementias: A Cross-Sectional Study on 1861 Patients. Neurobiology of Aging, 59, 1-9. https://doi.org/10.1016/j.neurobiolaging.2017.06.028
|
[23]
|
杨红旗, 陈生弟. 神经丝蛋白轻链在阿尔茨海默病诊断中的价值[J]. 阿尔茨海默病及相关病, 2020, 3(3): 177-181.
|
[24]
|
Mattsson, N., Insel, P.S., Palmqvist, S., et al. (2016) Cerebrospinal Fluid Tau, Neurogranin, and Neurofilament Light in Alzheimer’s Disease. EMBO Molecular Medi-cine, 8, 1184-1196. https://doi.org/10.15252/emmm.201606540
|
[25]
|
Hu, X., Yang, Y. and Gong, D. (2017) A Meta-Analysis of Cerebrospinal Fluid Visinin-Like Protein-1 in Alzheimer’s Disease Patients Relative to Healthy Con-trols and Mild Cognitive Impairment Patients. Neurosciences (Riyadh), 22, 94-101. https://doi.org/10.17712/nsj.2017.2.20160557
|
[26]
|
Portelius, E., Zetterberg, H., Skillbäck, T., et al. (2015) Cere-brospinal Fluid Neurogranin: Relation to Cognition and Neurodegeneration in Alzheimer’s Disease. Brain, 138, 3373-3385. https://doi.org/10.1093/brain/awv267
|
[27]
|
Jia, L., Zhu, M., Kong, C., et al. (2021) Blood Neu-ro-Exosomal Synaptic Proteins Predict Alzheimer’s Disease at the Asymptomatic Stage. Alzheimer’s & Dementia, 17, 49-60. https://doi.org/10.1002/alz.12166
|
[28]
|
Zarrouk, A., Debbabi, M., Bezine, M., et al. (2018) Lipid Biomarkers in Alzheimer’s Disease. Current Alzheimer Research, 15, 303-312. https://doi.org/10.2174/1567205014666170505101426
|
[29]
|
Varma, V.R., Oommen, A.M., Varma, S., et al. (2018) Brain and Blood Metabolite Signatures of Pathology and Progression in Alzheimer Disease: A Targeted Metabolomics Study. PLOS Medicine, 15, e1002482.
https://doi.org/10.1371/journal.pmed.1002482
|
[30]
|
Nho, K., Kueider-Paisley, A., Ahmad, S., et al. (2019) Associ-ation of Altered Liver Enzymes with Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebro-spinal Fluid Biomarkers. JAMA Network Open, 2, e197978.
https://doi.org/10.1001/jamanetworkopen.2019.7978
|
[31]
|
Dong, H., Li, J., Huang, L., et al. (2015) Serum Mi-croRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer’s Disease. Disease Markers, 2015, Article ID: 625659. https://doi.org/10.1155/2015/625659
|
[32]
|
Mahalingam, S. and Chen, M.K. (2019) Neuroimaging in Dementias. Seminars in Neurology, 39, 188-199.
https://doi.org/10.1055/s-0039-1678580
|
[33]
|
De Carli, F., Nobili, F., Pagani, M., et al. (2019) Accuracy and Gen-eralization Capability of an Automatic Method for the Detection of Typical Brain Hypometabolism in Prodromal Alz-heimer Disease. European Journal of Nuclear Medicine and Molecular Imaging, 46, 334-347. https://doi.org/10.1007/s00259-018-4197-7
|
[34]
|
陈超, 招建华, 卓文燕, 等. 阿尔茨海默病的18F-FDG PET脑显像特征及意义[J]. 中国实用神经疾病杂志, 2020, 23(17): 1484-1489.
|
[35]
|
Kadir, A., Almkvist, O., Forsberg, A., et al. (2012) Dynamic Changes in PET Amyloid and FDG Imaging at Different Stages of Alzheimer’s Disease. Neurobiology of Aging, 33, 198.e1-14.
https://doi.org/10.1016/j.neurobiolaging.2010.06.015
|
[36]
|
Dupont, A.C., Largeau, B., Santiago Ribeiro, M.J., et al. (2017) Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases. International Journal of Molecular Sciences, 18, 785. https://doi.org/10.3390/ijms18040785
|
[37]
|
Harper, L., Bouwman, F., Burton, E.J., et al. (2017) Patterns of Atro-phy in Pathologically Confirmed Dementias: A Voxelwise Analysis. Journal of Neurology, Neurosurgery and Psychia-try, 88, 908-916.
https://doi.org/10.1136/jnnp-2016-314978
|
[38]
|
Vemuri, P., Simon, G., Kantarci, K., et al. (2011) Antemortem Dif-ferential Diagnosis of Dementia Pathology Using Structural MRI: Differential-STAND. Neuroimage, 55, 522-531. https://doi.org/10.1016/j.neuroimage.2010.12.073
|
[39]
|
Chandra, A., Dervenoulas, G. and Politis, M. (2019) Alz-heimer’s Disease Neuroimaging Initiative. Magnetic Resonance Imaging in Alzheimer’s Disease and Mild Cognitive Im-pairment. Journal of Neurology, 266, 1293-1302.
https://doi.org/10.1007/s00415-018-9016-3
|
[40]
|
Qin, L., Guo, Z., McClure, M.A., et al. (2021) White Matter Changes from Mild Cognitive Impairment to Alzheimer’s Disease: A Meta-Analysis. Acta Neurologica Belgica, 121, 1435-1447. https://doi.org/10.1007/s13760-020-01322-5
|
[41]
|
Mirzaei, N., Shi, H., Oviatt, M., et al. (2020) Alz-heimer’s Retinopathy: Seeing Disease in the Eyes. Frontiers in Neuroscience, 14, Article No. 921. https://doi.org/10.3389/fnins.2020.00921
|
[42]
|
Asanad, S., Fantini, M., Sultan, W., et al. (2020) Retinal Nerve Fi-ber Layer Thickness Predicts CSF Amyloid/Tau Before Cognitive Decline. PLOS ONE, 15, e0232785. https://doi.org/10.1371/journal.pone.0232785
|
[43]
|
Ma, L., Chen, J., Wang, R., et al. (2015) The Level of Alz-heimer-Associated Neuronal Thread Protein in Urine May Be an Important Biomarker of Mild Cognitive Impairment. Journal of Clinical Neuroscience, 22, 649-652.
https://doi.org/10.1016/j.jocn.2014.10.011
|
[44]
|
Ashton, N.J., Ide, M., Zetterberg, H., et al. (2019) Salivary Bi-omarkers for Alzheimer’s Disease and Related Disorders. Neurology and Therapy, 8, 83-94. https://doi.org/10.1007/s40120-019-00168-1
|